The Middle EAST Contraceptive Drugs And Devices Market was valued at USD 1.5 billion in 2024 and is projected to reach USD 3.2 billion by 2034, registering a CAGR of 7.8%. This growth trajectory is underpinned by several factors, including increasing awareness of family planning, rising contraceptive prevalence rates, and a growing demand for reproductive health services. The region has seen a...